Public-private relationships in biobanking: A still underestimated key component of open innovation

Virchows Archiv

Volumn 464, Issue 1, 2014, Pages 3-9

  Hofman, Paul ^a,b   Bréchot, Christian ^c   Zatloukal, Kurt ^d   Dagher, Georges ^b   Clément, Bruno ^b,e  

^a PASTEUR HOSPITAL   (France)

^b INSERM   (France)

^c INSTITUT PASTEUR   (France)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Biobank; Bottlenecks; Contracts; Indicators; Private company; Public private partnerships; Research

Indexed keywords

BIOLOGY; DIAGNOSTIC PROCEDURE; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROGRAM SUSTAINABILITY; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; RISK BENEFIT ANALYSIS; TRANSLATIONAL RESEARCH; TURNAROUND TIME;

EID: 84893680865     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1524-z     Document Type: Review

References (29)

1. Hewitt RE (2011) Biobanking: the foundation of personalized medicine. Curr Opin Oncol 23(1):112-119
2. Shaw PM, Patterson SD (2011) The value of banked samples for oncology drug discovery and development. J Natl Cancer Inst Monogr 2011(42):46-49
3. Zatloukal K, Hainaut P (2010) Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine. Biomark Med 4(6):895-903
4. Luijten PR, van Dongen GA, Moonen CT, Storm G, Crommelin DJ (2012) Public-private partnerships in translational medicine: concepts and practical examples. J Control Release 161(2):416-421
5. OECD (2001) Biological resource centres: underpinning the future of life sciences and biotechnology. OECD, Paris, France
6. OECD (2004) Guidance for the operation of biological research centres (BRCs): certification and quality criteria for BRCs. OECD, Paris, France
7. National Cancer Institute, National Institutes of Health. National Cancer Institute Best Practices for Biospecimen Resources 2007. U.S.Department of Health and Human Services. http://biospecimens.cancer.gov/global/pdfs/NCI-Best- Practices-060507.pdf. Accessed 9 Dec 2013
8. Spencer B, Koutaissoff D, Lehr HA (2012) Informed consent: biobank donors should have a say. Nature 481(7382):443
9. Hofman V, Gaziello MC, Bonnetaud C, Ilie M, Mauro V, Long E, Selva E, Gavric-Tanga V, Lassalle S, Butori C, Papin-Michaud C, Lerda N, Bordone O, Coelle C, Sabourin JC, Chabannon C, Hofman P (2012) Setting up indicators in biobanking: why and how? Ann Pathol 32(2):91-101
10. Hofman V, Ilie M, Long E, Washetine K, Chabannon C, Figarella-Branger D, Clément B, Mabile L, Cambon-Thomsen A, Boucher P, Dagher G, Hewitt R, Parodi B, Hofman P (2013) Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output. Biopreserv Biobanking 11(4):235-244
11. Cambon-Thomsen A, Thorisson GA, Mabile L, Andrieu S, Bertier G, Boeckhout M, Cambon-Thomsen A, Carpenter J, Dagher G, Dalgleish R, Deschênes M, di Donato JH, Filocamo M, Goldberg M, Hewitt R, Hofman P, Kauffmann F, Leitsalu L, Lomba I, Mabile L, Melegh B, Metspalu A, Miranda L, Napolitani F, Oestergaard MZ, Parodi B, Pasterk M, Reiche A, Rial-Sebbag E, Rivalle G, Rochaix P, Susbielle G, Tarasova L, Thomsen M, Thorisson GA, Zawati MH, Zins M, BRIF workshop group (2011) The role of a bioresource research impact factor as an incentive to share human bioresources. Nat Genet 43(6):503-504
12. Gaffney EF, Madden D, Thomas GA (2012) The human side of cancer biobanking. Methods Mol Biol 823:59-77
13. Blackhall FH, Pintilie M, Wigle DA, Jurisica I, Liu N, Radulovich N, Johnston MR, Keshavjee S, Tsao MS (2004) Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia 6(6):761-767
14. Hofman V, Ilie M, Gavric-Tanga V, Lespinet V, Mari M, Lassalle S, Butori C, Coelle C, Bordone O, Selva E, Lamy A, Sabourin JC, Hofman P (2010) Role of the surgical pathology laboratory in the pre-analytical approach of molecular biology techniques. Ann Pathol 30(2):85-93
15. Ma Y, Dai H, Kong X (2012) Impact of warm ischemia on gene expression analysis in surgically removed biosamples. Anal Biochem 423(2):229-235
16. Micke P, Ohshima M, Tahmasebpoor S, Ren ZP, Ostman A, Pontén F, Botling J (2006) Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest 86(2):202-211
17. Simeon-Dubach D, Perren A (2011) Better provenance for biobank samples. Nature 475(7357):454-455
18. Scudellari M (2013) Biobank managers bemoan underuse of collected samples. Nat Med 19(3):253
19. Mabile L, Dalgleish R, Thorisson GA, Deschênes M, Hewitt R, Carpenter J, Bravo E, Filocamo M, Gourraud PA, Harris JR, Hofman P, Kauffmann F, Muñoz-Fernàndez MA, Pasterk M, Cambon-Thomsen A (2013) Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience 2(1):7. doi: 10.1186/2047-217X-2-7
20. Herpel E, Röcken C, Manke H, Schirmacher P, Flechtenmacher C (2010) Quality management and accreditation of research tissue banks: experience of the National Center for Tumor Diseases (NCT) Heidelberg. Virchows Arch 457(6):741-747
21. Chabannon C, Honstettre A, Daufresne LM, Martin PM, Bonnetaud C, Birtwisle-Peyrottes I, Romain S, Achache K, Mery O, Bordonne O, Ducord C, Jacotot L, Vaglio P, d'Arnoux C, Figarella-Branger D, Hofman P, Borg JP, Atger V (2010) Publication of biological samples collections catalogues by tumor banks. Bull Cancer 97(2):181-189
22. Master Z, Claudio JO, Rachul C, Wang JC, Minden MD, Caulfield T (2013) Cancer patient perceptions on the ethical and legal issues related to biobanking. BMC Med Genomics 6:8. doi: 10.1186/1755-8794-6-8
23. Rahm AK, Wrenn M, Carroll NM, Feigelson HS (2013) Biobanking for research: a survey of patient population attitudes and understanding. J Community Genet(Apr 20)
24. Hofman V, Bonnetaud C, Gaziello MC, Ilie M, Lassalle S, Butori C, Lerda N, Selva E, Gavric-Tanga V, Castillo L, Guevara N, Santini J, Pop D, Vénissac N, Mouroux J, Chabannon C, Hofman P (2010) The Nice CHU biobank experience to collect patients' informed consent for research context (2004-2009). Ann Pathol 30(5):337-343
25. Gottweis H, Gaskell G, Starkbaum J (2011) Connecting the public with biobank research: reciprocity matters. Nat Rev Genet 12(11):738-739
26. Steinsbekk KS, Ursin LO, Skolbekken JA, Solberg B (2013) We're not in it for the money - lay people's moral intuitions on commercial use of 'their' biobank. Med Health Care Philos 16(2):151-162
27. Anderlik M (2003) Commercial biobanks and genetic research: ethical and legal issues. Am J Pharmacogenomics 3(3):203-215
28. Vaught J, Rogers J, Carolin T, Compton C (2011) Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr 2011(42):24-31
29. Tukacs E, Korotij A, Maros-Szabo Z, Molnar AM, Hajdu A, Torok Z (2012) Model requirements for biobank software systems. Bioinformation 8(6):290-292